Activated Cyclin-Dependent Kinase 5 Promotes Microglial Phagocytosis of Fibrillar β-Amyloid by Up-regulating Lipoprotein Lipase Expression*

Amyloid plaques are crucial for the pathogenesis of Alzheimer disease (AD). Phagocytosis of fibrillar β-amyloid (Aβ) by activated microglia is essential for Aβ clearance in Alzheimer disease. However, the mechanism underlying Aβ clearance in the microglia remains unclear. In this study, we performed stable isotope labeling of amino acids in cultured cells for quantitative proteomics analysis to determine the changes in protein expression in BV2 microglia treated with or without Aβ. Among 2742 proteins identified, six were significantly up-regulated and seven were down-regulated by Aβ treatment. Bioinformatic analysis revealed strong over-representation of membrane proteins, including lipoprotein lipase (LPL), among proteins regulated by the Aβ stimulus. We verified that LPL expression increased at both mRNA and protein levels in response to Aβ treatment in BV2 microglia and primary microglial cells. Silencing of LPL reduced microglial phagocytosis of Aβ, but did not affect degradation of internalized Aβ. Importantly, we found that enhanced cyclin-dependent kinase 5 (CDK5) activity by increasing p35-to-p25 conversion contributed to LPL up-regulation and promoted Aβ phagocytosis in microglia, whereas inhibition of CDK5 reduced LPL expression and Aβ internalization. Furthermore, Aβ plaques was increased with reducing p25 and LPL level in APP/PS1 mouse brains, suggesting that CDK5/p25 signaling plays a crucial role in microglial phagocytosis of Aβ. In summary, our findings reveal a potential role of the CDK5/p25-LPL signaling pathway in Aβ phagocytosis by microglia and provide a new insight into the molecular pathogenesis of Alzheimer disease.

[1]  Bradley T. Hyman,et al.  Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta , 2013, Neuron.

[2]  Alberto D. Pascual-Montano,et al.  GeneCodis3: a non-redundant and modular enrichment analysis tool for functional genomics , 2012, Nucleic Acids Res..

[3]  G. Landreth,et al.  Apolipoprotein E Promotes β-Amyloid Trafficking and Degradation by Modulating Microglial Cholesterol Levels* , 2011, The Journal of Biological Chemistry.

[4]  Jamaal A Rehman,et al.  TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease , 2011, Journal of Neuroinflammation.

[5]  F. Maxfield,et al.  Degradation of Alzheimer's amyloid fibrils by microglia requires delivery of ClC-7 to lysosomes , 2011, Molecular biology of the cell.

[6]  D. Farfara,et al.  γ‐Secretase component presenilin is important for microglia β‐amyloid clearance , 2011, Annals of neurology.

[7]  D. Roberts,et al.  Amyloid-β Inhibits No-cGMP Signaling in a CD36- and CD47-Dependent Manner , 2010, PloS one.

[8]  M. Michikawa,et al.  Lipoprotein Lipase Is a Novel Amyloid β (Aβ)-binding Protein That Promotes Glycosaminoglycan-dependent Cellular Uptake of Aβ in Astrocytes* , 2010, The Journal of Biological Chemistry.

[9]  J. Grutzendler,et al.  CX3CR1 in Microglia Regulates Brain Amyloid Deposition through Selective Protofibrillar Amyloid-β Phagocytosis , 2010, The Journal of Neuroscience.

[10]  Jesús Avila,et al.  Role of glycogen synthase kinase-3 in Alzheimer’s disease pathogenesis and glycogen synthase kinase-3 inhibitors , 2010, Expert review of neurotherapeutics.

[11]  G. Landreth,et al.  Microglia and inflammation in Alzheimer's disease. , 2010, CNS & neurological disorders drug targets.

[12]  Z. Su,et al.  Src kinase activation is mandatory for MDA-9/syntenin-mediated activation of Nuclear Factor-κB , 2010, Oncogene.

[13]  D. Baker,et al.  Inflammation in neurodegenerative diseases , 2010, Immunology.

[14]  J. Witton,et al.  Increase in the density of resting microglia precedes neuritic plaque formation and microglial activation in a transgenic model of Alzheimer's disease , 2010, Cell death & disease.

[15]  D. Holtzman,et al.  The Role of Apolipoprotein E in Alzheimer's Disease , 2009, Neuron.

[16]  S. Rivest.  Regulation of innate immune responses in the brain , 2009, Nature Reviews Immunology.

[17]  Francisco Tirado,et al.  GeneCodis: interpreting gene lists through enrichment analysis and integration of diverse biological information , 2009, Nucleic Acids Res..

[18]  M. Mann,et al.  Universal sample preparation method for proteome analysis , 2009, Nature Methods.

[19]  A. Alcamí,et al.  Identification of TRIM23 as a Cofactor Involved in the Regulation of NF-κB by Human Cytomegalovirus , 2009, Journal of Virology.

[20]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[21]  K. Moore,et al.  The NALP3 inflammasome is involved in the innate immune response to amyloid-β , 2008, Nature Immunology.

[22]  D. Holtzman,et al.  ApoE Promotes the Proteolytic Degradation of Aβ , 2008, Neuron.

[23]  Shengdi Chen,et al.  Predominant release of lysosomal enzymes by newborn rat microglia after LPS treatment revealed by proteomic studies. , 2008, Journal of proteome research.

[24]  Anna Kremer,et al.  Neurodegeneration and neuroinflammation in cdk5/p25-inducible mice: a model for hippocampal sclerosis and neocortical degeneration. , 2008, The American journal of pathology.

[25]  F. Maxfield,et al.  Activation of microglia acidifies lysosomes and leads to degradation of Alzheimer amyloid fibrils. , 2007, Molecular biology of the cell.

[26]  G. Braus,et al.  Cyclin-dependent kinase 5 is an upstream regulator of mitochondrial fission during neuronal apoptosis , 2007, Cell Death and Differentiation.

[27]  M. Mann,et al.  A practical recipe for stable isotope labeling by amino acids in cell culture (SILAC) , 2006, Nature Protocols.

[28]  M. Larsen,et al.  Highly selective enrichment of phosphorylated peptides using titanium dioxide , 2006, Nature Protocols.

[29]  L. Tsai,et al.  p25/Cyclin-Dependent Kinase 5 Induces Production and Intraneuronal Accumulation of Amyloid β In Vivo , 2006, The Journal of Neuroscience.

[30]  J. Poirier,et al.  A polymorphism in lipoprotein lipase affects the severity of Alzheimer's disease pathophysiology , 2006, The European journal of neuroscience.

[31]  S. Lockett,et al.  Activation of Toll-like Receptor 2 on Microglia Promotes Cell Uptake of Alzheimer Disease-associated Amyloid β Peptide* , 2006, Journal of Biological Chemistry.

[32]  J. Koenigsknecht-Talboo,et al.  Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines , 2005, The Journal of Neuroscience.

[33]  H. Neumann,et al.  LPS receptor (CD14): a receptor for phagocytosis of Alzheimer's amyloid peptide. , 2005, Brain : a journal of neurology.

[34]  B. P. Kota,et al.  An overview on biological mechanisms of PPARs. , 2005, Pharmacological research.

[35]  K. Moore,et al.  β-Amyloid promotes accumulation of lipid peroxides by inhibiting CD36-mediated clearance of oxidized lipoproteins , 2004, Journal of Neuroinflammation.

[36]  G. Landreth,et al.  Microglial Phagocytosis of Fibrillar β-Amyloid through a β1 Integrin-Dependent Mechanism , 2004, The Journal of Neuroscience.

[37]  S. Paul,et al.  Apolipoprotein E promotes astrocyte colocalization and degradation of deposited amyloid-β peptides , 2004, Nature Medicine.

[38]  J. Serratosa,et al.  High‐yield isolation of murine microglia by mild trypsinization , 2003, Glia.

[39]  R. Qi,et al.  Protein-Protein Interactions in Cdk5 Regulation and Function , 2003, Neurosignals.

[40]  L. Tsai,et al.  Life is a journey: a genetic look at neocortical development , 2002, Nature Reviews Genetics.

[41]  M. Mann,et al.  Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics* , 2002, Molecular & Cellular Proteomics.

[42]  B. Wolozin.  A fluid connection: Cholesterol and Aβ , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Loike,et al.  Scavenger receptor class B type I (SR-BI) mediates adhesion of neonatal murine microglia to fibrillar β-amyloid , 2001, Journal of Neuroimmunology.

[44]  L. Tsai,et al.  Neurotoxicity induces cleavage of p35 to p25 by calpain , 2000, Nature.

[45]  L. Tsai,et al.  Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegeneration , 1999, Nature.

[46]  J. Auwerx,et al.  3‐Hydroxy‐3‐methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C‐III and lipoprotein lipase , 1999, FEBS letters.

[47]  C. Pang,et al.  Lipoprotein lipase mutations and Alzheimer's disease. , 1999, American journal of medical genetics.

[48]  L. Hersh,et al.  Insulin-degrading Enzyme Regulates Extracellular Levels of Amyloid β-Protein by Degradation* , 1998, The Journal of Biological Chemistry.

[49]  Douglas R. McDonald,et al.  Amyloid Fibrils Activate Tyrosine Kinase-Dependent Signaling and Superoxide Production in Microglia , 1997, The Journal of Neuroscience.

[50]  F. Maxfield,et al.  Microglial Cells Internalize Aggregates of the Alzheimer's Disease Amyloid β-Protein Via a Scavenger Receptor , 1996, Neuron.

[51]  L. Tsai,et al.  p35 is a neural-specific regulatory subunit of cyclin-dependent kinase 5 , 1994, Nature.

[52]  R. Frants,et al.  Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. , 1993, The Journal of biological chemistry.

[53]  K. Williams,et al.  Mechanisms by which lipoprotein lipase alters cellular metabolism of lipoprotein(a), low density lipoprotein, and nascent lipoproteins. Roles for low density lipoprotein receptors and heparan sulfate proteoglycans. , 1992, The Journal of biological chemistry.

[54]  C. Chang,et al.  Synthesis and regulation of lipoprotein lipase in the hippocampus. , 1990, Journal of lipid research.

[55]  D. Butterfield,et al.  Role of oxidative stress in the progression of Alzheimer's disease. , 2010, Journal of Alzheimer's disease : JAD.

[56]  Jürgen Cox,et al.  A practical guide to the MaxQuant computational platform for SILAC-based quantitative proteomics , 2009, Nature Protocols.

[57]  Journal of Neuroinflammation BioMed Central , 2006 .

[58]  B. Hyman,et al.  Microglial response to amyloid plaques in APPsw transgenic mice. , 1998, The American journal of pathology.